SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-187182
Filing Date
2022-07-01
Accepted
2022-07-01 16:02:05
Documents
14
Period of Report
2022-07-01
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d361322d8k.htm   iXBRL 8-K 42616
2 EX-3.1 d361322dex31.htm EX-3.1 7382
3 EX-3.2 d361322dex32.htm EX-3.2 46882
  Complete submission text file 0001193125-22-187182.txt   243244

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srra-20220701.xsd EX-101.SCH 2865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220701_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220701_pre.xml EX-101.PRE 11713
8 EXTRACTED XBRL INSTANCE DOCUMENT d361322d8k_htm.xml XML 3547
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 221061338
SIC: 2834 Pharmaceutical Preparations